ERD

ERDERA | EUROPEAN RARE DISEASES RESEARCH ALLIANCE

01-09-2024

-

31-08-2031

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

3TR | Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

01-09-2019

-

31-08-2026

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

c4c | conect4children (COllaborative Network for European Clinical Trials For Children)

01-05-2018

-

30-04-2025

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

AIMS-2-TRIALS | Autism Innovative Medicine Studies – 2 – Trials

01-06-2018

-

31-05-2025

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

IDEA-FAST | Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

01-11-2019

-

30-04-2026

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

BIGPICTURE | Central Repository for Digital Pathology

01-02-2021

-

31-01-2027

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

Gravitate-Health | Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment

01-11-2020

-

31-10-2025

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

EU-ToxRisk | An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century

01-01-2016

-

31-12-2021

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

IDERHA | Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance

01-04-2023

-

31-03-2028

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

Maxima Butterfly | From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network

01-01-2023

-

31-12-2027

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

SCREEN4CARE | Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies

01-10-2021

-

30-09-2026

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

PARADIGM | Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

01-03-2018

-

30-11-2020

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

DO-IT | Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055

01-02-2017

-

31-01-2019

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

OPTIMA | Optimal treatment for patients with solid tumours in Europe through Artificial intelligence

01-10-2021

-

30-09-2026

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064

01-01-2017

-

31-12-2023

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

iCARE4CVD | INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE

01-10-2023

-

31-03-2028

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

VICT3R | Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

01-09-2024

-

29-02-2028

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

PREFER | Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966

01-10-2016

-

31-05-2022

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

ADAPT-SMART | Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

01-07-2015

-

30-04-2018

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

PharmaLedger | PharmaLedger

01-01-2020

-

31-12-2022

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

TransBioLine | Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease

01-02-2019

-

31-01-2025

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

eTRANSAFE | Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management

01-09-2017

-

28-02-2023

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

EPND | European platform for neurodegenerative disorders

01-11-2021

-

31-10-2026

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

PREMIER | Prioritisation and Risk Evaluation of Medicines in the EnviRonment

01-09-2020

-

31-08-2026

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

FACILITATE | FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem

01-01-2022

-

31-12-2025

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

ROADMAP | Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020

01-11-2016

-

31-10-2018

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

R2D2-MH | Risk and Resilience in Developmental Diversity and Mental Health

01-09-2022

-

31-08-2027

Show more information

Organisation F. Hoffmann-La Roche AG

GUIDE.MRD | GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD

01-05-2023

-

30-04-2028

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

IMPROVE | Framework to IMPROVE the Integration of Patient Generated Health Data to Facilitate Value Based Healthcare

01-12-2023

-

30-11-2028

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

imSAVAR | Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

01-12-2019

-

30-11-2025

Show more information

Organisation F. HOFFMANN-LA ROCHE AG

Projects overview

Selected filters:

ERDERA | EUROPEAN RARE DISEASES RESEARCH ALLIANCE

3TR | Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

c4c | conect4children (COllaborative Network for European Clinical Trials For Children)

AIMS-2-TRIALS | Autism Innovative Medicine Studies – 2 – Trials

IDEA-FAST | Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

BIGPICTURE | Central Repository for Digital Pathology

Gravitate-Health | Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment

EU-ToxRisk | An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century

IDERHA | Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance

Maxima Butterfly | From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network

SCREEN4CARE | Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies

PARADIGM | Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.

DO-IT | Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055

OPTIMA | Optimal treatment for patients with solid tumours in Europe through Artificial intelligence

ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064

iCARE4CVD | INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE

VICT3R | Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

PREFER | Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966

ADAPT-SMART | Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890

PharmaLedger | PharmaLedger

TransBioLine | Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease

eTRANSAFE | Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management

EPND | European platform for neurodegenerative disorders

PREMIER | Prioritisation and Risk Evaluation of Medicines in the EnviRonment

FACILITATE | FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem

ROADMAP | Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020

R2D2-MH | Risk and Resilience in Developmental Diversity and Mental Health

GUIDE.MRD | GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD

IMPROVE | Framework to IMPROVE the Integration of Patient Generated Health Data to Facilitate Value Based Healthcare

imSAVAR | Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies